ResearchMoz

China Diagnostic Reagent Industry Report, 2012-2014

Research In China
Published Date » 2013-01-04
No. Of Pages » 86
   
 Chinas diagnostic reagent industry has formed a certain market scale and basis, and is marching from the introduction stage to the growth stage. With the continuous growth in Chinas medical care investment and per capita health care spending, the Chinas diagnostic reagent market has a promising prospect.  
   
 In vitro diagnostic reagents account for more than 90.0% of the output of Chinas diagnostic reagent industry. In 2011, the market scale of in vitro diagnostic reagents reached about RMB 11.4 billion in China, the industry will maintain a growth rate of 15%-20% in the future, and the market scale will hit RMB 20.8 billion in 2015.  
   
 At present, there are only a few integrated in vitro diagnostic reagent enterprises with strong strength in Chinas diagnostic...
Table of Content

1. Overview of Diagnostic Reagent Industry
1.1 Definition
1.2 Classification

2. China Diagnostic Reagent Industry

2.1 Overview
2.2 Market Structure
2.3 Import and Export
2.3.1 Import
2.3.2 Export
2.4 Competitive Landscape
2.4.1 Biochemical Diagnostic Reagents
2.4.2 Immune Diagnostic Reagents
2.4.3 Molecular Diagnostic Reagents
2.4.4 Integrated In Vitro Diagnostic Reagents
2.5 Profitability
2.6 Entry Barriers
2.6.1 Technical Barriers
2.6.2 Quality and Brand Barriers
2.6.3 Marketing Channel Barriers
2.6.4 Market Access Barriers

3. Development Environment of China Diagnostic Reagent Industry
3.1 Policy Environment
3.1.1 Regulatory Policy
3.1.2 Industry Policy
3.2 Upstream and Downstream Industries
3.2.1 Industrial Chain
3.2.2 Upstream
3.2.3 Downstream

4. Development Forecast of China Diagnostic Reagent Industry
4.1 Overall Forecast
4.1.1 Market Demand Drivers
4.1.2 Market Scale Forecast
4.2 Development Trends of Diagnostic Reagent Industry
4.2.1 Biochemical Diagnosis and Immunodiagnosis Will Still Be the Mainstream
4.2.2 Industry Concentration Will Increase
4.2.3 Enterprises with Complete Product Line Integrating Reagents and Instruments will Win

5. Major Chinese Diagnostic Reagent Enterprises

5.1 Shanghai Kehua Bio-engineering Co., Ltd. (KHB)
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 R & D and Investment
5.1.6 Customers
5.1.7 Diagnostic Reagent Business
5.1.8 Forecast and Prospect
5.2 Da An Gene Co., Ltd.
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 R & D and Investment
5.2.6 Diagnostic Reagent Business
5.2.7 Forecast and Prospect
5.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 R & D and Investment
5.3.6 Diagnostic Reagent Business
5.3.7 Forecast and Prospect
5.4 BioSino Bio-technology and Science Inc.
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 R & D and Investment
5.4.5 Forecast and Prospect
5.5 Beijing Kinghawk Pharmaceutical Co., Ltd.
5.5.1 Profile
5.5.2 Operation
5.5.3 Revenue Structure
5.5.4 Gross Margin
5.5.5 Diagnostic Reagent Business
5.5.6 Forecast and Prospect
5.6 Livzon Pharmaceutical Group Inc.
5.6.1 Profile
5.6.2 Operation
5.6.3 Revenue Structure
5.6.4 Gross Margin
5.6.5 Diagnostic Reagent Business
5.6.6 Forecast and Prospect
5.7 Beijing Leadman Biochemistry Co., Ltd.
5.7.1 Profile
5.7.2 Operation
5.7.3 Revenue Structure
5.7.4 Gross Margin
5.7.5 R & D and Investment
5.7.6 Customers
5.7.7 Diagnostic Reagent Business
5.7.8 Forecast and Prospect
5.8 Acon Biotech (Hangzhou) Co., Ltd.
5.8.1 Profile
5.8.2 Operation
5.8.3 Development
5.9 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
5.9.1 Profile
5.9.2 Operation
5.9.3 Development
5.10 Shanghai Rongsheng Biotech Co., Ltd. (Rsbio)
5.10.1 Profile
5.10.2 Operation
5.10.3 Development
5.11 Shenzhen PG Biotech Co., Ltd.
5.11.1 Profile
5.11.2 Operation
5.12 Shanghai Upper Bio-Tech Pharma Co., Ltd.
5.12.1 Profile
5.12.2 Operation
5.12.3 Development
5.13 Inverness Medical (Shanghai) Co., Ltd.
5.13.1 Profile
5.13.2 Operation
5.14 Blue Cross Bio-Medical (Beijing) Co., Ltd.
5.14.1 Profile
5.14.2 Operation
5.14.3 Development
5.15 Beijing North Institute of Biological Technology (BNIBT)
5.15.1 Profile
5.15.2 Operation
5.15.3 Development

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Arthroscopy Procedures And Products Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
By - Transparency Market Research
Description The global arthroscopy market is expected to undergo rapid growth in the next few years. Arthroscopy is a minimally invasive orthopedic surgical procedure in which examination of joints and their treatment is performed. Arthroscopic procedures are thus primarily performed to evaluate or treat certain orthopedic conditions such as torn cartilage, ACL reconstruction and others. Arthroscopy is preferred over open surgical methods because of the advantages of this procedure such as non-requirement of opening the joint completely, reduction of recovery time, less risk of...
Inorganic Functional Materials Market - Global Industry Analysis, Size, Share, Trends And Forecast 2014 - 2020
By - Transparency Market Research
Inorganic functional materials are predominantly used in the electrical and electronic industries.  Inorganic functional materials typically comprise boron compound, aluminum compound, copper compound, indium compound, gallium compound, manganese compound, lithium compound, titanium compound, silicon compound and zinc compound among others. These inorganic functional materials are largely used in industries such as electronic equipment manufacturing, electronic devices and printed circuit boards manufacturing, smart packaging and smart labels production among others. The growing...
Lyme Disease Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Lyme disease is an infectious disease caused by bacterial species borrelia. It is a tick borne disease caused by the transmission to humans by the bite of infected ticks. Patients infected with lyme disease suffer from symptoms such as fever, depression, fatigue and skin rashes. If the disease is diagnosed at an early stage then it can be treated with antibiotics. However, if the disease is left untreated then it affects heart, joint and central nervous system and might become a cause for death. The lyme disease diagnostic market is segmented on the basis of diagnostic tests,...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

SESI Project Kick Starts with a Grand Opening
Apr 20, 2015  
On Thursday, the Stanford Energy Systems Innovations (SESI) project succeeded with the grand opening of their Central Energy Facility which is located close to the golf course. The facility has provided with a private tour and reception, and introduced John Hennessy as the President of University, Tom Werner as the President and CEO of SunPower, and other executives and officials of...
China Is Planning to Shut Down Most of its Coal Plants
Apr 20, 2015  
China has been taking some efforts to scrap some of its small-sized coal plants which will avoid releasing about 11.4 million metric tons every year of carbon dioxide which was warming the climate and helping the whole nation with reduced emissions. This reduction will be for the first time in almost a decade. This impact is a hint of what is going to happen in China which will push...
CPEC to be on the High-Agenda in the Two Day Pakistan Visit of Chinese President
Apr 20, 2015  
According to Xinhua, a lot of deals varying from infrastructure to energy to culture and education will be signed and agreed during the two-day visit of China President Xi Jinping in Pakistan visit which will begin from Monday.This will be Xi Jinping’s first visit among all the South Asian countries from 2013, from when he holds the position of the presidentship. During the...
China Reduces Bank Reserve Requirement to Overcome Slowdown
Apr 20, 2015  
The central bank of China on Sunday reduced the amount of capital, which banks must maintain as reserves. This reduction is the second cut in 2 months that will affect the entire industry, by adding additional liquidity to the second-largest economy of the world in supporting to promote bank lending and fight declining growth rate. The PBOC (People's Bank of China) has decreased the...
ICICI Bank Partners with Tech Mahindra, Rolled out Tap-n-Pay Service
Apr 20, 2015  
One of the leading private sector banks in India, ICICI Bank, has entered into a partnership with Tech Mahindra to roll out the contactless payment service, named 'Tap-n-Pay'. ICICI Bank stated in an announcement that based on the NFC (Near Field Communications) technology, this payment method enables anyone, irrespective of having an account with ICICI, to make over-the-counter...